PROCYSBI
These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994
d3a3ec28-f746-463a-bb92-3bc8826db09e
HUMAN PRESCRIPTION DRUG LABEL
Feb 22, 2022
Horizon Therapeutics USA, Inc.
DUNS: 033470838
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cysteamine bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Cysteamine bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Cysteamine bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Cysteamine bitartrate
Product Details
FDA regulatory identification and product classification information